XOFLX Trademark
Trademark Overview
On Wednesday, January 29, 2025, a trademark application was filed for XOFLX with the United States Patent and Trademark Office. The USPTO has given the XOFLX trademark a serial number of 79417533. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, February 24, 2026. This trademark is owned by Oxford Genetics Ltd. The XOFLX trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Product design and development services relating to the creation and alteration of chemical and biological reagents; scientific design services relating to the creation and alteration of nucleic acids in the nature of nucleic recombinant acids and synthetic deoxyribonucleic acids; scientific design services, namely, development relating to the creation and alteration of recombinant viruses; scientific design services relating to the creation and alteration of lentiviruses, lentivirus particles and lentivirus plasmids; scientific research, product development and bioengineering services relating to lentiviruses; drug discovery services; scientific design services relating to the creation and alteration of cell lines, elementary cells and parts thereof being drug discovery services; scientific design services, namely, development relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services
Chemical and biological preparations for use in science and industry; nucleic acids for laboratory use; nucleic recombinant acids for laboratory use, synthetic deoxyribonucleic acids for laboratory use; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes, namely, immortalized mammalian cell lines; microorganisms for non-medical purposes being cultures of microorganisms other than for medical and veterinary use; human and animal cells and parts thereof for scientific and research purposes, namely, immortalized mammalian cell lines; cultures of microorganisms for scientific and research purposes; viral vectors being chemicals and biological preparations for use in science and industry; lentiviruses, lentivirus particles and lentivirus plasmids being chemicals and biological preparations, all for scientific and research purposes
Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes, namely, immortalized mammalian cell lines; preparations of microorganisms for medical and veterinary purposes; viral vectors being biological preparations derived from tissue cultures for medical and veterinary purposes; lentiviruses, lentivirus particles and lentivirus plasmids being biological preparations, all for medical and veterinary use, namely, for the treatment of cardiovascular, degenerative, dermatological, endocrine, gastrointestinal, genetic, gynaecological, neurological, infectious, immunological, metabolic, oncological, ophthalmic, respiratory and urological disorders and diseases
General Information
| Serial Number | 79417533 |
| Word Mark | XOFLX |
| Filing Date | Wednesday, January 29, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, February 24, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 17, 2026 |
Trademark Statements
| Goods and Services | Product design and development services relating to the creation and alteration of chemical and biological reagents; scientific design services relating to the creation and alteration of nucleic acids in the nature of nucleic recombinant acids and synthetic deoxyribonucleic acids; scientific design services, namely, development relating to the creation and alteration of recombinant viruses; scientific design services relating to the creation and alteration of lentiviruses, lentivirus particles and lentivirus plasmids; scientific research, product development and bioengineering services relating to lentiviruses; drug discovery services; scientific design services relating to the creation and alteration of cell lines, elementary cells and parts thereof being drug discovery services; scientific design services, namely, development relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services |
| Goods and Services | Chemical and biological preparations for use in science and industry; nucleic acids for laboratory use; nucleic recombinant acids for laboratory use, synthetic deoxyribonucleic acids for laboratory use; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes, namely, immortalized mammalian cell lines; microorganisms for non-medical purposes being cultures of microorganisms other than for medical and veterinary use; human and animal cells and parts thereof for scientific and research purposes, namely, immortalized mammalian cell lines; cultures of microorganisms for scientific and research purposes; viral vectors being chemicals and biological preparations for use in science and industry; lentiviruses, lentivirus particles and lentivirus plasmids being chemicals and biological preparations, all for scientific and research purposes |
| Goods and Services | Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes, namely, immortalized mammalian cell lines; preparations of microorganisms for medical and veterinary purposes; viral vectors being biological preparations derived from tissue cultures for medical and veterinary purposes; lentiviruses, lentivirus particles and lentivirus plasmids being biological preparations, all for medical and veterinary use, namely, for the treatment of cardiovascular, degenerative, dermatological, endocrine, gastrointestinal, genetic, gynaecological, neurological, infectious, immunological, metabolic, oncological, ophthalmic, respiratory and urological disorders and diseases |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 20, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 20, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 20, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Oxford Genetics Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
Trademark Events
| Event Date | Event Description |
| Thursday, February 20, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Sunday, February 23, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, February 23, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, July 9, 2025 | ASSIGNED TO EXAMINER |
| Thursday, July 10, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, July 11, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, August 18, 2025 | REFUSAL PROCESSED BY MPU |
| Monday, August 18, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, September 5, 2025 | REFUSAL PROCESSED BY IB |
| Sunday, October 19, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Sunday, October 19, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Sunday, October 19, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Sunday, October 19, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Sunday, October 19, 2025 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, January 21, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, January 21, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, January 21, 2026 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| Wednesday, January 21, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, January 22, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 22, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 22, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 19, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 11, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
